Heart Failure Clinical trials 2024: EMA, PDMA, FDA Approvals, Pipeline, Medication, Treatment Market, ROA, MOA and Companies by DelveInsight | Abbott, Berlin Heart GmbH, Biotronik, Boston Scientific, Lepu Medical, etc

(Albany, United States) As per DelveInsight's assessment, globally, Heart Failure pipeline constitutes 75+ key companies continuously working towards developing 90+ Heart Failure treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Heart Failure Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Heart Failure Market.

The Heart Failure Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for Sample Report @ https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key takeaways from the Heart Failure Pipeline Report:
• Heart Failure Companies across the globe are diligently working toward developing novel Heart Failure treatment therapies with a considerable amount of success over the years.
• Heart Failure companies working in the treatment market are Tenaya Therapeutics, Athersys, TransThera Biosciences, SalubrisBio, Ionis Pharmaceuticals, Arena Pharmaceuticals, Palatin Technologies, Bayer HealthCare, Eli Lilly and Company, and others, are developing therapies for the Heart Failure treatment
• Emerging Heart Failure therapies in the different phases of clinical trials are- TN-301, Invimestrocel, TT-00920, JK-07, IONIS AGT LRx, APD418, PL-3994, Finerenone, Tirzepatide, and others are expected to have a significant impact on the Heart Failure market in the coming years.
• In April 2024, The EMPACT-MI phase III clinical trial demonstrated a 10% relative risk reduction in the primary composite endpoint of time to first hospitalization due to heart failure or all-cause mortality for Jardiance® (empagliflozin) compared to placebo, though the results did not achieve statistical significance. Jardiance was administered to adults within 14 days of an acute myocardial infarction (heart attack) and showed a reassuring safety profile among this patient group.
• In January 2024, Bayer and its subsidiary Asklepios BioPharmaceutical (AskBio) have initiated the Phase II clinical trial for AB-1002, an investigational gene therapy aimed at treating congestive heart failure (CHF). This trial aims to evaluate the efficacy and safety of AB-1002 in adults diagnosed with non-ischemic cardiomyopathy, specifically those classified as NYHA Class III Heart Failure. Known as Gene PHosphatase Inhibition Therapy (GenePHIT), the study is a multicenter, double-blind, adaptive, placebo-controlled, randomized trial designed to assess the effects of a single intracoronary dose of AB-1002.
• In September 2023, Bayer has initiated three investigator-sponsored Phase III clinical trials to assess Kerendia (finerenone) for treating heart failure. Kerendia, a top-selling drug for Bayer, generated €67 million ($72.6 million) in sales in Q2 2023 according to the company's half-year report. GlobalData projects that sales could reach $1.4 billion by 2029.

Heart Failure Overview
Heart failure is a chronic medical condition where the heart muscle is unable to pump blood efficiently enough to meet the body's needs for oxygen and nutrients. This can result from various underlying conditions that weaken or damage the heart, such as coronary artery disease, high blood pressure, or previous heart attacks. Symptoms of heart failure include shortness of breath, fatigue, swelling in the legs, ankles, or abdomen, and difficulty exercising.

Get a Free Sample PDF Report to know more about Heart Failure Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Emerging Heart Failure Drugs Under Different Phases of Clinical Development Include:
• TN-301: Tenaya Therapeutics
• Invimestrocel: Athersys
• TT-00920: TransThera Biosciences
• JK-07: SalubrisBio
• IONIS AGT LRx: Ionis Pharmaceuticals
• APD418: Arena Pharmaceuticals
• PL-3994: Palatin Technologies
• Finerenone: Bayer HealthCare Pharmaceuticals
• Tirzepatide: Eli Lilly and Company

Heart Failure Route of Administration
Heart Failure pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Heart Failure Molecule Type
Heart Failure Products have been categorized under various Molecule types, such as
• Oligonucleotide
• Peptide
• Small molecule

Heart Failure Pipeline Therapeutics Assessment
• Heart Failure Assessment by Product Type
• Heart Failure By Stage and Product Type
• Heart Failure Assessment by Route of Administration
• Heart Failure By Stage and Route of Administration
• Heart Failure Assessment by Molecule Type
• Heart Failure by Stage and Molecule Type

DelveInsight's Heart Failure Report covers around 90+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Heart Failure product details are provided in the report. Download the Heart Failure pipeline report to learn more about the emerging Heart Failure therapies
https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key companies in the Heart Failure Therapeutics Market include:
Key companies developing therapies for Heart Failure are - Abbott Laboratories, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, Jarvik Heart Inc., Lepu Medical Technology (Beijing)Co.,Ltd., Magenta Medical Ltd, MEDICO S.R.L., Medtronic PLC, Oscor, Inc., OSYPKA MEDICAL, Shree Pacetronix Ltd, and others.

Heart Failure Pipeline Analysis:
The Heart Failure pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Heart Failure with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Heart Failure Treatment.
• Heart Failure key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Heart Failure Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Heart Failure market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Heart Failure drugs and therapies
https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Heart Failure Pipeline Market Drivers
• Alongside these drug launches, a new therapeutic strategy is being explored, prevalence of chronic heart failure on the rise, strong collaboration between main stakeholders of therapeutic innovation: scientific community, industry and regulatory agencies are some of the important factors that are fueling the Heart Failure Market.

Heart Failure Pipeline Market Barriers
• However, true surrogate marker for mortality in heart failure (HF) remains elusive, high cost of approved therapies, transition of a clinical HFrEF project from one stage of development to the next is still associated with considerable development risk and other factors are creating obstacles in the Heart Failure Market growth.

Scope of Heart Failure Pipeline Drug Insight
• Coverage: Global
• Key Heart Failure Companies: Tenaya Therapeutics, Athersys, TransThera Biosciences, SalubrisBio, Ionis Pharmaceuticals, Arena Pharmaceuticals, Palatin Technologies, Bayer HealthCare, Eli Lilly and Company, and others
• Key Heart Failure Therapies: TN-301, Invimestrocel, TT-00920, JK-07, IONIS AGT LRx, APD418, PL-3994, Finerenone, Tirzepatide, and others
• Heart Failure Therapeutic Assessment: Heart Failure current marketed and Heart Failure emerging therapies
• Heart Failure Market Dynamics: Heart Failure market drivers and Heart Failure market barriers

Request for Sample PDF Report for Heart Failure Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Heart Failure Report Introduction
2. Heart Failure Executive Summary
3. Heart Failure Overview
4. Heart Failure- Analytical Perspective In-depth Commercial Assessment
5. Heart Failure Pipeline Therapeutics
6. Heart Failure Late Stage Products (Phase II/III)
7. Heart Failure Mid Stage Products (Phase II)
8. Heart Failure Early Stage Products (Phase I)
9. Heart Failure Preclinical Stage Products
10. Heart Failure Therapeutics Assessment
11. Heart Failure Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Heart Failure Key Companies
14. Heart Failure Key Products
15. Heart Failure Unmet Needs
16 . Heart Failure Market Drivers and Barriers
17. Heart Failure Future Perspectives and Conclusion
18. Heart Failure Analyst Views
19. Appendix
20. About DelveInsight

Trending Reports:
• Bladder Cancer Market: https://www.delveinsight.com/report-store/bladder-cancer-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Cardiac Biomarkers Testing Devices Market: https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Epilepsy Market: https://www.delveinsight.com/report-store/epilepsy-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Generalized Pustular Psoriasis Market: https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Neuromodulation Devices Market: https://www.delveinsight.com/report-store/neuromodulation-devices-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neurotrophic Keratitis Market: https://www.delveinsight.com/report-store/neurotrophic-keratitis-market
• Post Traumatic Stress Disorder Market: https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-market
• Post-bariatric Hypoglycemia Market: https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-market
• Absssi Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Acute Gout Flare Market: https://www.delveinsight.com/report-store/acute-gout-flare-market
• Adrenoleukodystrophy Market: https://www.delveinsight.com/report-store/adrenoleukodystrophy-market
• Adult Myopia Market: https://www.delveinsight.com/infographics/adult-myopia-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Anemia In Ckd Market: https://www.delveinsight.com/report-store/anemia-in-chronic-kidney-disease-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Artificial Lung Devices Market: https://www.delveinsight.com/report-store/artificial-lung-devices-pipeline-insight-and-competitive-landscape
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Cardiac Amyloidosis Market: https://www.delveinsight.com/report-store/cardiac-amyloidosis-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-release-system-market
• Centronuclear Myopathy Market: https://www.delveinsight.com/report-store/centronuclear-myopathy-cnm-pipeline-insight
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Competitive Intelligence Pharma: https://www.delveinsight.com/blog/competitive-intelligence-in-healthcare-sector
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Cutaneous T Cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.